http://rdf.disgenet.org/resource/nanopub/NP1362013.RAka-Bud1jCw_psj_SUtYPcfVdXGsb3xF5C6u-uxlIfgY
type: Nanopublication
created: 2016-05-13T12:52:03+02:00
rights: http://opendatacommons.org/licenses/odbl/1.0/
rights holder: IBIGroup
subject: SIO_000983
used data: disgenetv3.0rdf
authored by: http://orcid.org/0000-0001-5999-6269
authored by: http://orcid.org/0000-0002-7534-7661
authored by: 0000-0002-9383-528X
authored by: http://orcid.org/0000-0003-0169-8159
authored by: http://orcid.org/0000-0003-1244-7654
created by: http://orcid.org/0000-0003-0169-8159
version: v4.0.0.0

http://rdf.disgenet.org/resource/nanopub/NP1362013.RAka-Bud1jCw_psj_SUtYPcfVdXGsb3xF5C6u-uxlIfgY130_assertion
type: Assertion
description: [The current criteria for breast cancer staging include pathologic parameters, such as tumor size and nodal involvement, histologic and cytologic parameters, such as histologic grade, and biologic parameters such as age of the patient, hormone (estrogen and progesterone) receptor status, oncogene activation (e.g., c-myc and HER-2/neu) and tumor suppressor gene inactivation (e.g., p53).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
evidence: DisGeNET evidence - LITERATURE
SIO_000772: http://identifiers.org/pubmed/8907151
was generated by: ECO_0000203

befree-2016
imported on: 2016-02-19

DisGeNET evidence - LITERATURE
type: ECO_0000212
comment: Gene-disease associations inferred from text-mining the literature.

disgenetv3.0rdf
version: v4.0.0